Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,276 | 800 | 99.9% |
| Education | $21.40 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,622 | 73 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,236 | 74 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,087 | 50 | $0 (2024) |
| Lilly USA, LLC | $1,013 | 59 | $0 (2024) |
| ABBVIE INC. | $997.02 | 63 | $0 (2024) |
| Novo Nordisk Inc | $983.03 | 71 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $556.82 | 34 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $532.81 | 36 | $0 (2023) |
| GlaxoSmithKline, LLC. | $493.63 | 28 | $0 (2024) |
| PFIZER INC. | $457.16 | 31 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,663 | 84 | Lilly USA, LLC ($234.85) |
| 2023 | $1,648 | 82 | Amgen Inc. ($233.46) |
| 2022 | $1,473 | 85 | Lilly USA, LLC ($237.74) |
| 2021 | $1,796 | 97 | Amgen Inc. ($245.05) |
| 2020 | $1,588 | 88 | AstraZeneca Pharmaceuticals LP ($250.26) |
| 2019 | $2,203 | 119 | Amgen Inc. ($301.49) |
| 2018 | $1,940 | 122 | AstraZeneca Pharmaceuticals LP ($223.64) |
| 2017 | $1,986 | 126 | Boehringer Ingelheim Pharmaceuticals, Inc. ($294.86) |
All Payment Transactions
803 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: NEUROSCIENCE | ||||||
| 12/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.87 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: VACCINES | ||||||
| 12/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $6.40 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: DIABETES | ||||||
| 12/10/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Bone Health | ||||||
| 12/04/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.57 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.76 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Gastroenterology | ||||||
| 11/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: Biological | ||||||
| 11/06/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $2.22 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Obesity | ||||||
| 10/16/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/01/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: Neurology | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Gastroenterology | ||||||
| 09/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: Biological | ||||||
| 09/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $27.51 | General |
| Category: DIABETES | ||||||
| 09/03/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 08/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $31.57 | General |
| Category: Diabetes | ||||||
| 08/14/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart, Flector | Food and Beverage | Cash or cash equivalent | $23.31 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,521 | 3,109 | $394,585 | $187,526 |
| 2022 | 22 | 1,490 | 2,948 | $372,873 | $176,965 |
| 2021 | 19 | 1,353 | 2,770 | $332,802 | $162,921 |
| 2020 | 18 | 1,278 | 2,475 | $283,020 | $124,987 |
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 200 | 995 | $248,750 | $113,428 | 45.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 134 | 134 | $29,350 | $20,431 | 69.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 113 | 114 | $10,830 | $8,097 | 74.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 56 | 68 | $10,200 | $5,319 | 52.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 192 | 595 | $8,925 | $4,998 | 56.0% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 26 | 26 | $10,100 | $4,782 | 47.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 26 | 26 | $14,010 | $4,550 | 32.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 118 | 119 | $7,160 | $4,282 | 59.8% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 70 | 102 | $7,650 | $4,129 | 54.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 17 | 17 | $4,250 | $3,318 | 78.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 30 | 55 | $4,675 | $3,234 | 69.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 172 | 229 | $13,170 | $2,976 | 22.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 125 | 125 | $6,250 | $2,760 | 44.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 44 | 174 | $8,700 | $2,249 | 25.8% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 19 | 28 | $2,380 | $928.59 | 39.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 40 | 47 | $1,175 | $751.07 | 63.9% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 11 | 11 | $1,650 | $513.15 | 31.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 76 | 88 | $810.00 | $300.08 | 37.0% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 14 | 15 | $375.00 | $243.00 | 64.8% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 26 | 126 | $3,425 | $145.49 | 4.2% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 12 | 15 | $750.00 | $92.12 | 12.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 204 | 877 | $219,250 | $102,146 | 46.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 104 | 104 | $22,700 | $16,311 | 71.9% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 43 | 44 | $17,000 | $8,557 | 50.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 77 | 96 | $14,400 | $7,780 | 54.0% |
About Dr. William Klein, MD
Dr. William Klein, MD is a Internal Medicine healthcare provider based in Great Neck, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659359578.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Klein, MD has received a total of $14,297 in payments from pharmaceutical and medical device companies, with $1,663 received in 2024. These payments were reported across 803 transactions from 60 companies. The most common payment nature is "Food and Beverage" ($14,276).
As a Medicare-enrolled provider, Klein has provided services to 5,642 Medicare beneficiaries, totaling 11,302 services with total Medicare billing of $652,399. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Great Neck, NY
- Active Since 01/03/2006
- Last Updated 05/03/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1659359578
Products in Payments
- FARXIGA (Drug) $896.52
- JARDIANCE (Drug) $749.43
- Otezla (Drug) $646.56
- XIFAXAN (Drug) $526.64
- Ozempic (Drug) $511.70
- XARELTO (Drug) $475.70
- MOUNJARO (Drug) $447.71
- TRULICITY (Drug) $427.32
- EVENITY (Biological) $404.25
- UBRELVY (Drug) $301.56
- TRINTELLIX (Drug) $293.09
- Vascepa (Drug) $292.47
- VRAYLAR (Drug) $288.49
- Synthroid (Drug) $249.64
- SHINGRIX (Biological) $245.93
- Aimovig (Biological) $240.79
- Prolia (Biological) $239.23
- CONTRAVE (Drug) $235.59
- Trintellix (Drug) $221.46
- TRADJENTA (Drug) $205.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Great Neck
Dr. Jamie Hirsch, Md, MD
Internal Medicine — Payments: $69,165
Joanne Lee, M.d, M.D
Internal Medicine — Payments: $36,469
Bernard Rosof
Internal Medicine — Payments: $26,679
Dr. Shahram Shamekh, Md, MD
Internal Medicine — Payments: $18,187
Sanford Ratner, M.d, M.D
Internal Medicine — Payments: $16,933
David Edelson, Md, MD
Internal Medicine — Payments: $15,163